Guo S - Search Results

1

Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.

Song H, Li H, Guo S, Pan Y, Fu Y, Zhou Z, Li Z, Wen X, Sun X, He B, Gu H, Zhao Q, Wang C, An P, Luo S, Hu Y, Xie X, Lu B. Song H, et al. Among authors: guo s. Brain. 2018 Jun 1;141(6):1782-1798. doi: 10.1093/brain/awy081. Brain. 2018. PMID: 29608652 Free PMC article.

2

Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms.

Li J, Tian Y, Guo S, Gu H, Yuan Q, Xie X. Li J, et al. Among authors: guo s. PLoS One. 2018 Jan 19;13(1):e0191469. doi: 10.1371/journal.pone.0191469. eCollection 2018. PLoS One. 2018. PMID: 29351556 Free PMC article.

3

Design and optimization of 2,3-dihydrobenzo[b][1,4]dioxine propanoic acids as novel GPR40 agonists with improved pharmacokinetic and safety profiles.

Guo B, Guo S, Huang J, Li J, Li J, Chen Q, Zhou X, Xie X, Yang Y. Guo B, et al. Among authors: guo s. Bioorg Med Chem. 2018 Dec 1;26(22):5780-5791. doi: 10.1016/j.bmc.2018.10.019. Epub 2018 Oct 22. Bioorg Med Chem. 2018. PMID: 30392954

4

Synthesis and biological evaluation of novel potent FFA1 agonists containing 2,3-dihydrobenzo[b][1,4]dioxine.

Kong D, Guo S, Yang Y, Guo B, Xie X, Hu W. Kong D, et al. Among authors: guo b, guo s. Bioorg Med Chem Lett. 2019 Mar 15;29(6):848-852. doi: 10.1016/j.bmcl.2019.01.014. Epub 2019 Jan 17. Bioorg Med Chem Lett. 2019. PMID: 30685095

5

Structural basis of ligand recognition and self-activation of orphan GPR52.

Lin X, Li M, Wang N, Wu Y, Luo Z, Guo S, Han GW, Li S, Yue Y, Wei X, Xie X, Chen Y, Zhao S, Wu J, Lei M, Xu F. Lin X, et al. Among authors: guo s. Nature. 2020 Mar;579(7797):152-157. doi: 10.1038/s41586-020-2019-0. Epub 2020 Feb 19. Nature. 2020. PMID: 32076264

6

GPR52 Antagonist Reduces Huntingtin Levels and Ameliorates Huntington's Disease-Related Phenotypes.

Wang C, Zhang YF, Guo S, Zhao Q, Zeng Y, Xie Z, Xie X, Lu B, Hu Y. Wang C, et al. Among authors: guo s. J Med Chem. 2021 Jan 28;64(2):941-957. doi: 10.1021/acs.jmedchem.0c01133. Epub 2020 Nov 13. J Med Chem. 2021. PMID: 33185430

7

Targeted Proteomics Combined with Affinity Mass Spectrometry Analysis Reveals Antagonist E7 Acts As an Intracellular Covalent Ligand of Orphan Receptor GPR52.

Ma M, Guo S, Lin X, Li S, Wu Y, Zeng Y, Hu Y, Zhao S, Xu F, Xie X, Shui W. Ma M, et al. Among authors: guo s. ACS Chem Biol. 2020 Dec 18;15(12):3275-3284. doi: 10.1021/acschembio.0c00867. Epub 2020 Dec 1. ACS Chem Biol. 2020. PMID: 33258587

8

Correction to GPR52 Antagonist Reduces Huntingtin Levels and Ameliorates Huntington's Disease-Related Phenotypes.

Wang C, Zhang YF, Guo S, Zhao Q, Zeng Y, Xie Z, Xie X, Lu B, Hu Y. Wang C, et al. Among authors: guo s. J Med Chem. 2021 Jan 28;64(2):1220-1221. doi: 10.1021/acs.jmedchem.0c01981. Epub 2020 Dec 8. J Med Chem. 2021. PMID: 33291869 No abstract available.

9

Identification of Betulinic Acid Derivatives as Potent TGR5 Agonists with Antidiabetic Effects via Humanized TGR5^H88Y Mutant Mice.

Yun Y, Zhang C, Guo S, Liang X, Lan Y, Wang M, Zhuo N, Yin J, Liu H, Gu M, Li J, Xie X, Nan F. Yun Y, et al. Among authors: guo s. J Med Chem. 2021 Aug 26;64(16):12181-12199. doi: 10.1021/acs.jmedchem.1c00851. Epub 2021 Aug 18. J Med Chem. 2021. PMID: 34406006

10

Molecular recognition of an acyl-peptide hormone and activation of ghrelin receptor.

Wang Y, Guo S, Zhuang Y, Yun Y, Xu P, He X, Guo J, Yin W, Xu HE, Xie X, Jiang Y. Wang Y, et al. Among authors: guo s, guo j. Nat Commun. 2021 Aug 20;12(1):5064. doi: 10.1038/s41467-021-25364-2. Nat Commun. 2021. PMID: 34417468 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,599 results

Search Page

Filters